Xvivo Perfusion AB (publ) XVIVO.ST
XVIVO.ST
Xvivo Perfusion AB (publ) CEVI.ST
CellaVision AB (publ) SUS.ST
Surgical Science Sweden AB (publ) SECARE.ST
Swedencare AB (publ) IMP-A-SDB.ST
Implantica AG STIL.ST
Stille AB CRAD-B.ST
C-Rad AB (publ) BICO.ST
BICO Group AB (publ) PAX.ST
Paxman AB (publ) RAY-B.ST
RaySearch Laboratories AB (publ)
Xvivo Perfusion AB (publ) CEVI.ST
CellaVision AB (publ) SUS.ST
Surgical Science Sweden AB (publ) SECARE.ST
Swedencare AB (publ) IMP-A-SDB.ST
Implantica AG STIL.ST
Stille AB CRAD-B.ST
C-Rad AB (publ) BICO.ST
BICO Group AB (publ) PAX.ST
Paxman AB (publ) RAY-B.ST
RaySearch Laboratories AB (publ)
Performance
| Periode | XVIVO.ST | CEVI.ST | SUS.ST | SECARE.ST | IMP-A-SDB.ST | STIL.ST | CRAD-B.ST | BICO.ST | PAX.ST | RAY-B.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -35.91 % | 17.32 % | -27.22 % | 11.27 % | 104.23 % | -7.58 % | 13.37 % | -38.60 % | -3.26 % | -2.17 % |
| YTD | -65.52 % | -12.91 % | -40.48 % | -17.01 % | 67.58 % | -8.88 % | 13.18 % | -32.38 % | -2.40 % | 1.12 % |
| 1Y | -64.08 % | -33.26 % | -25.72 % | -0.40 % | 40.19 % | -8.02 % | -8.47 % | -44.93 % | 5.16 % | 41.33 % |
| 3Y | 26.00 % | -38.29 % | -39.63 % | -11.11 % | 15.11 % | 59.84 % | -4.56 % | -40.16 % | 57.87 % | 319.78 % |
| 5Y | -26.60 % | -39.29 % | 1.80 % | -15.61 % | -34.20 % | 133.81 % | -17.49 % | -88.93 % | 144.19 % | 182.31 % |
| 10Y | 236.95 % | 262.96 % | 712.61 % | 1 011.11 % | -40.04 % | 1 150.00 % | 86.40 % | 62.50 % | 498.17 % | 114.29 % |
| From the beginning | 831.05 % | 1 080.77 % | 712.61 % | 1 011.11 % | -40.04 % | 417.35 % | 135.17 % | 62.50 % | 498.17 % | 3 534.89 % |